Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center.

Qiu, Xianxin; Gao, Jing; Hu, Jiyi; Yang, Jing; Hu, Weixu; Huang, Qingting; Zhang, Haojiong; Lu, Jiade J; Kong, Lin

Qiu, Xianxin; Gao, Jing; Hu, Jiyi; Yang, Jing; Hu, Weixu; Huang, Qingting; Zhang, Haojiong; Lu, Jiade J; Kong, Lin.

Affiliation

Qiu X; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Gao J; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
Hu J; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Yang J; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Hu W; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
Huang Q; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Zhang H; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Lu JJ; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
Kong L; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.

J Neurooncol ; 162(3): 503-514, 2023 May.

Article de En | MEDLINE | ID: mdl-36583815

Sujet(s)
Mots clés

Diffuse gliomas; Efficacy; Isocitrate dehydrogenase; Proton radiotherapy; Toxicities

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oligodendrogliome / Ions lourds / Tumeurs du tronc cérébral / Gliome Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: J Neurooncol Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google